The association of metabolic syndrome and Chlamydia pneumoniae, helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: The Persian Gulf healthy heart study

Cardiovascular Diabetology

Volumn 5, Issue , 2006, Pages

  Nabipour, Iraj ^a   Vahdat, Katayon ^a   Jafari, Seyed Mojtaba ^a   Pazoki, Raha ^a   Sanjdideh, Zahra ^a  

^a BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD ANALYSIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HIGH RISK POPULATION; HUMAN; IRAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; PATHOGENESIS; POPULATION RESEARCH; RISK FACTOR; SEX DIFFERENCE;

ADULT; ANTIGENS, BACTERIAL; CHLAMYDOPHILA PNEUMONIAE; CROSS-SECTIONAL STUDIES; CYTOMEGALOVIRUS; HEART DISEASES; HELICOBACTER PYLORI; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOGLOBULIN G; INDIAN OCEAN; IRAN; METABOLIC SYNDROME X; RISK FACTORS;

EID: 33845602247     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-5-25     Document Type: Article

References (23)

1. Liese AD, Mayer-Davis EJ, Haffner SM: Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev 1998, 20:157-172.
2. Grundy S: Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002, 105:2696-2698.
3. Ford ES, Giles WH, Mokdad AH: Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004, 27:2444-2449.
4. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States Adults. Circulation 2004, 110:1245-1250.
5. Devaraj S, Rosenson RS, Jialal I: Metabolic syndrome:an appraisal of the proinflamatory and pro-coagulant status. Endocrinol Metabol Clin N Am 2004, 33:431-453.
6. Siscovick DS, Schwartz SM, Corey L, Grayston JT, Ashley R, Wang SP, Psaty BM, Tracy RP, Kuller LH, Kronmal RA: Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease in older adults: The Cardiovascular Heart Study. Circulation 2000, 102:2335-2340.
7. Aristo V: A look at infectious agents as a possible causative factor in cardiovascular disease. Science 2003, 34:6-11.
8. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
9. Xu Q, Schett G, Perschinka H, Mayr M, Egger G, Oberhollenzer F, Willeit J, Kiechl S, Wick G: Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 2000, 102:14-20.
10. Andel M, Tsevegjav A, Roubalova K, Hruba D, Iouhy P, Kraml P: Infectious and inflammatory factors in the etiology and pathogenesis of atherosclerosis. Vnitr lek 2003, 94:960-966.
11. Vercellotti GM: Microbs, inflammation and atherosclerosis: will old pathology lessons guide new therapies? Trans Am Clin Climatol Assoc 2001, 112:215-222.
12. Willerson JT, Ridker PM: Inflammation as a cardiovascular risk factor. Circulation 2004, 109:11-2-11-10.
13. Ridker PM, Buring JE, Cook NR, Rifai N: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8 year follow up of 14719 initially healthy American women. Circulation 2003, 107:391-397.
14. Rose R: Atherosclerosis: an inflammatory disease? N Engl J Med 1999, 340:115-126.
15. Danesh J, Whincup PI, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB: Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Br Med J 2000, 321:199-204.
16. Fernandez-Real JM, Wifredo R: Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocrine Review 2003, 24:278-301.
17. Fisman EZ, Motro M, Tenenbaum A: Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof. Cardiovasc Diabetol 2003, 2:11.
18. Fisman EZ, Motro M, Tenenbaum A: Regulation of adipocytokines and insulin resistance. Cardiovasc Diabetol 2003, 2:11.
19. Engelman JA, Berg AH, Lewis RY, Lisanti MP, Scherer PE: Tumor necrosis factor-alpha mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes. Mol Endo 2000, 14:1557-1569.
20. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994, 3:1271-1278.
21. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC: Acute phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990, 12:1179-1186.
22. Fasshauer M, Paschke R: Regulation of adipocytokines and insulin resistance. Diabetologia 2003, 46:1594-603.
23. Pickup JC, Mattock MB, Chusney GD, Burt D: NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome. Diabetologia 1997, 40:1286-1292.